-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Cabazil is a new generation of yew drugs
Recently, researchers from Japan published an article in World J Urol analyzing the clinical indicators
The researchers conducted a retrospective study
The study eventually included 57 patients who received cabataraces (median 4 cycles, range 1-27) starting at a starting dose of 15-25 mg/m2
Prognostic analysis of overall survival in baseline factors after CBZ treatment
In summary, previous androgen receptor-targeted therapy is the only risk factor
Original Source:
Yoshiyuki Yamamoto , Makoto Ishii , Akihiro Yoshimura et al.